Back to Authors

McCann, Georgia A.

A5034906868 | I165951966

Mayo Clinic

The University of Texas at San Antonio Health Science Center

Citations 2

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

JAMA Oncology | June 13, 2019 | Volume: 5 | Issue: 8 | Pages: 1132

10.1001/jamaoncol.2019.1029 | PMID 31194225

TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 1011-1011

10.1200/jco.2018.36.15_suppl.1011